Top 100 2025
Company
Amal Therapeutics SA
Incorporated
September 2012
Headquarter
Genève
Biotech Biotech Cancer Drug development platforms Drug discovery Protein drugs Vaccines

Cancer vaccines

Amal Therapeutics SA, a spin-off from the University of Geneva, is developing new cancer vaccines, using with a proprietary family of vectors.

Company News

Find here the latest news about the company.

Company Awards